Abstract
Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular mechanisms might uncover drug targets for osteoporosis. Several pathways are emerging from current research, including membrane ion channels, ATP signaling, and second messengers such as prostaglandins and nitric oxide. Some key molecular targets include the Ltype calcium channel (alpha 1C isoform), a gadolinium-sensitive stretch-activated channel, P2Y2 and P2X7 purinergic receptors, EP2 and EP4 prostanoid receptors, and the parathyroid hormone receptor. One characteristic of the mechanosensing apparatus that has only recently been studied is the important role of desensitization. Experimental protocols that insert “rest” periods to reduce the effects of desensitization can double anabolic responses to mechanical loading. A drug therapy that suppresses desensitization pathways may provide an effective means to build bone strength.
Keywords: bone strength, bone density, osteoporosis, purinergic receptors, parathyroid hormone, nitric oxide, prostaglandin, desensitization
Current Pharmaceutical Design
Title: Exercise as an Anabolic Stimulus for Bone
Volume: 10 Issue: 21
Author(s): Charles H. Turner and Alexander G. Robling
Affiliation:
Keywords: bone strength, bone density, osteoporosis, purinergic receptors, parathyroid hormone, nitric oxide, prostaglandin, desensitization
Abstract: Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular mechanisms might uncover drug targets for osteoporosis. Several pathways are emerging from current research, including membrane ion channels, ATP signaling, and second messengers such as prostaglandins and nitric oxide. Some key molecular targets include the Ltype calcium channel (alpha 1C isoform), a gadolinium-sensitive stretch-activated channel, P2Y2 and P2X7 purinergic receptors, EP2 and EP4 prostanoid receptors, and the parathyroid hormone receptor. One characteristic of the mechanosensing apparatus that has only recently been studied is the important role of desensitization. Experimental protocols that insert “rest” periods to reduce the effects of desensitization can double anabolic responses to mechanical loading. A drug therapy that suppresses desensitization pathways may provide an effective means to build bone strength.
Export Options
About this article
Cite this article as:
Turner H. Charles and Robling G. Alexander, Exercise as an Anabolic Stimulus for Bone, Current Pharmaceutical Design 2004; 10 (21) . https://dx.doi.org/10.2174/1381612043383755
DOI https://dx.doi.org/10.2174/1381612043383755 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular and Molecular Mechanisms of Apoptosis in Age-Related Muscle Atrophy
Current Aging Science Ras Family Small GTPase-Mediated Neuroprotective Signaling in Stroke
Central Nervous System Agents in Medicinal Chemistry The Neuroimmunoendocrine Network in the Complex Host-Parasite Relationship During Murine Cysticercosis
Current Topics in Medicinal Chemistry Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug- Eluting Stent Systems
Current Pharmaceutical Design Structure, Function and Biological Relevance of Prolyl Oligopeptidase
Current Protein & Peptide Science Macrocycle Molecules for the Management of Systemic Infections: the Clarithromycin Paradigm
Current Topics in Medicinal Chemistry <I>Prunus Armeniaca L</I>. Seed Extract and Its Amygdalin Containing Fraction Induced Mitochondrial-Mediated Apoptosis and Autophagy in Liver Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry The Outbreak of Coronavirus Disease 2019 (COVID-19) and its Manifestation
Coronaviruses Insights into Immunophilin Structure and Function
Current Medicinal Chemistry Lipoprotein(a): Current Perspectives
Current Vascular Pharmacology Meet Our Editorial Board Member
Medicinal Chemistry Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Current Drug Targets Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
Current Medicinal Chemistry Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities
Current Pharmaceutical Design Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and Production
Current Pharmaceutical Design Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
Current Pharmaceutical Design Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses
Current Alzheimer Research Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations
Current Pharmacogenomics and Personalized Medicine Hepatitis C Infection Influence on Immune Recovery in HIV-Positive Patients on Successful HAART: The Role of Genotype 3
Current HIV Research